Get started

JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd - Breakout Setup, Move is ON...#JAGSNPHARM trading above Resistance of 706 Next Resistance is at 936 Support is at 506 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:JAGSNPHARMLong
by MandeepSinghKohli
Jagsonpal Pharmaceuticals Ltd - Breakout Setup, Move is ON...#JAGSNPHARM trading above Resistance of 506 Next Resistance is at 706 Support is at 439 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:JAGSNPHARMLong
by MandeepSinghKohli
Target 1 achieved in JAGSNPHARM. Gain of 67% Target 2 is ON.This is follow-up on Jagsonpal Pharmaceuticals. Can check link to related ideas. Target 1 achieved. Gain of more than 67%. Target 2 is ON. Chart is self explanatory. Entry, Targets and Trailing Stop Loss are mentioned on the chart. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:JAGSNPHARMLong
by MandeepSinghKohli
5
Jagsonpal Pharma High Volume Breakout1. Buy or Sell at your own risk 2. Don't risk more than 1%-2% of your capital as stop loss 3. Position Size formula:- Stop Loss/(Buy Price-Initial Stop Loss Price) 4. Sell on initial stop loss hit or close below daily supertrend (for short term traders) or close below weekly supertrend (for long term investors) After a TTM sales and profit growth of 24% and 83% respectively, NSE:JAGSNPHARM gave a high-volume breakout on Friday. As the market condition is volatile, one should wait for a pullback in this stock up to Rs.179-Rs. 187 range and then buy if stock prices breaks out above Rs. 213 with a stop loss just below the pullback low. Aggressive investors can buy with a stop at or below Rs. 174. Other Fundamentals: - 1. ROE at 15%, ROCE at 18%, Promoter holding at 70.3% 2. Current Ratio at 1.95 (greater than 1.5 is good), Debt to Equity at 0.06 (less than 0.5 is good and debt came down from 38 in 2016 to 7 in Sep'21), Interest Coverage at 97 (greater than 3 is good) 3. FCF to CFO at 122% (company won't need to borrow for capex in future) 4. Debtor days improved from 49 in Mar'20 to 25 in Mar'21 5. FII position increased From 0.11 to 0.20 since Sep'21 Only one negative for this company: - The company has entered into an agreement with Suvinys Developers Private Limited for Supply of Product Dydrogesterone. Suvinys Developers Private Limited will supply Dydrogesterone to Jagsonpal Pharmaceuticals Limited. Directors of Suvinys Developers Private Limited, Rajpal Singh Kochhar is also the managing director of Jagsonpal Pharmaceuticals. This may be a Red Flag.
NSE:JAGSNPHARMLong
by akashbothra